Ucb Pharma Italia joins Federated Innovation @Mind, a new model that brings together public and private entities that, benefiting from the Mind ecosystem (Milan Innovation District), develop innovation projects in the ‘Future of Health’ and ‘City of the Future’ fields. The pharmaceutical company announces this in a note, specifying that, with respect to the 11 thematic areas in which the Federated Innovation @Mind companies are grouped, Ucb Pharma Italia is part of Life Sciences & Healthcare to work with its Research and Innovation team at development of cross-tech ideas, favoring a profitable contamination between the various players who will have an interest in working within the sector to which they belong.
Federated Innovation @Mind, which today brings together 37 partner companies – recalls Ucb – is a unique model that aims to generate research and innovation initiatives and promote technology transfer on a platform open to the collaboration of all: companies, universities, start-ups, investors and talents. The company includes companies ranging from Greentech & Circular Economy, to Urban Digital Tech, from Agrifood Tech to Energy to Construction Tech. The model, in compliance with antitrust regulations, intends to go beyond classic open innovation, with a legal structure to protect intellectual property, which allows for the collection of new ideas and projects, developing them quickly and linearly with predefined operating methods and procedures, to make them available to everyone, thus placing himself as an innovation developer. Each project is called upon to respond to specific strategic priorities and challenges. After an experimentation phase, a competition follows which sees each company or group of companies collaborating to develop innovative projects.
The Life Sciences & Healthcare cluster, thanks to new technologies, aims to create an ssystem of services designed for the well-being of citizens and the development of an innovative and personalized healthcare model that can help people live longer and healthier lives. Companies belonging to the same product sector are invited to cooperate with their competitors, in full compliance with competition rules, and with less structured and younger companies, just as projects proposed by different thematic areas are favored, with the aim to multiply the opportunities for technological development and acceleration of innovative processes.
Born in February 2021, Federated Innovation @Mind is promoted by Lendlease, a real estate company, leader in the regeneration of urban areas, as head of design and private development of Mind, with the contribution of Cariplo Factory as a catalyst. The companies that become partners of Federated Innovation @Mind create a real community of innovators, also thanks to the presence of researchers, students and clinicians from the State University of Milan, Irccs Galeazzi and the Human Technopole Foundation.
“We are very pleased to have become part of Federated innovation @Mind – declared Federico Chinni, CEO of Ucb Pharma Italia – an ambitious and challenging project that aims to develop transversal innovation in many industrial sectors on the basis of principle ‘Collaborate to Compete’ between the various companies that take part in it. Ucb Pharma has always set itself the goal of promoting innovation models in the field of life sciences, and we are convinced that this is the ideal context to achieve the model of the cities of the future that intends to find solutions to the challenges of the great changes taking place throughout the world “.
#Ucb #Italia #Federated #Innovation #Mind